Neural circuit selective for fast but not slow dopamine increases in drug reward.
Peter ManzaDardo TomasiEhsan Shokri-KojoriRui ZhangDanielle S KrollDana FeldmanKatherine L McPhersonCatherine BieseckerEvan DennisAllison JohnsonKai YuanWen-Tung WangMichele-Vera YongaGene-Jack WangNora D VolkowPublished in: Nature communications (2023)
The faster a drug enters the brain, the greater its addictive potential, yet the brain circuits underlying the rate dependency to drug reward remain unresolved. With simultaneous PET-fMRI we linked dynamics of dopamine signaling, brain activity/connectivity, and self-reported 'high' in 20 adults receiving methylphenidate orally (results in slow delivery) and intravenously (results in fast delivery) (trial NCT03326245). We estimated speed of striatal dopamine increases to oral and IV methylphenidate and then tested where brain activity was associated with slow and fast dopamine dynamics (primary endpoint). We then tested whether these brain circuits were temporally associated with individual 'high' ratings to methylphenidate (secondary endpoint). A corticostriatal circuit comprising the dorsal anterior cingulate cortex and insula and their connections with dorsal caudate was activated by fast (but not slow) dopamine increases and paralleled 'high' ratings. These data provide evidence in humans for a link between dACC/insula activation and fast but not slow dopamine increases and document a critical role of the salience network in drug reward.
Keyphrases
- functional connectivity
- resting state
- uric acid
- prefrontal cortex
- attention deficit hyperactivity disorder
- spinal cord
- white matter
- adverse drug
- neuropathic pain
- randomized controlled trial
- clinical trial
- computed tomography
- drug induced
- pet ct
- multiple sclerosis
- positron emission tomography
- risk assessment
- big data
- electronic health record
- spinal cord injury
- network analysis